Last updated on April 2019

Addressing Dementia Via Agitation-Centered Evaluation


Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.

Clinical Study Identifier: NCT03226522

Find a site near you

Start Over

Meridian Research

Brooksville, FL United States
  Connect »

Axsome Study Site

Phoenix, AZ United States
  Connect »

Axsome study site

Scottsdale, AZ United States
  Connect »

Axsome Study Site

Tucson, AZ United States
  Connect »

Axsome Study Site

Little Rock, AR United States
  Connect »

Axsome study site

Canoga Park, CA United States
  Connect »

Axsome study site

Costa Mesa, CA United States
  Connect »

Axsome study site

Fresno, CA United States
  Connect »

Axsome study site

Long Beach, CA United States
  Connect »

Axsome study site

Riverside, CA United States
  Connect »

Axsome study site

Sacramento, CA United States
  Connect »

Axsome study site

Santa Ana, CA United States
  Connect »

Axsome study site

Sherman Oaks, CA United States
  Connect »

Axsome study site

Simi Valley, CA United States
  Connect »

Axsome study site

Temecula, CA United States
  Connect »

Axsome study site

Ventura, CA United States
  Connect »

Axsome Study Site

Colorado Springs, CO United States
  Connect »

Axsome study site

Cromwell, CT United States
  Connect »

Axsome study site

New London, CT United States
  Connect »

Axsome study site

Boca Raton, FL United States
  Connect »

Axsome study site

Boynton Beach, FL United States
  Connect »

Axsome Study Site

Coconut Creek, FL United States
  Connect »

Axsome study site

Hallandale Beach, FL United States
  Connect »

Axsome study site

Hialeah, FL United States
  Connect »

Axsome Study Site

Lake City, FL United States
  Connect »

Axsome study site

Miami, FL United States
  Connect »

Axsome study site

Pensacola, FL United States
  Connect »

Axsome study site

Spring Hill, FL United States
  Connect »

Axsome study site

Tampa, FL United States
  Connect »

Axsome study site

Atlanta, GA United States
  Connect »

Axsome study site

Decatur, GA United States
  Connect »

Axsome Study Site

Honolulu, HI United States
  Connect »

Axsome study site

Boise, ID United States
  Connect »

Axsome Study Site

Flossmoor, IL United States
  Connect »

Axsome study site

Avon, IN United States
  Connect »

Axsome Study Site

Overland Park, KS United States
  Connect »

Axsome Study Site

Topeka, KS United States
  Connect »

Axsome study site

Baton Rouge, LA United States
  Connect »

Axsome Study Site

Lake Charles, LA United States
  Connect »

Axsome study site

Chesterfield, MO United States
  Connect »

Axsome study site

Las Vegas, NV United States
  Connect »

Axsome Study Site

Princeton, NJ United States
  Connect »

Axsome study site

Toms River, NJ United States
  Connect »

Axsome study site

Brooklyn, NY United States
  Connect »

Axsome study site

New York, NY United States
  Connect »

Axsome study site

Staten Island, NY United States
  Connect »

Axsome study site

Charlotte, NC United States
  Connect »

Axsome Study Site

Winston-Salem, NC United States
  Connect »

Axsome study site

Cincinnati, OH United States
  Connect »

Axsome study site

Shaker Heights, OH United States
  Connect »

Axsome study site

DeSoto, TX United States
  Connect »

Axsome study site

Wichita Falls, TX United States
  Connect »

Axsome study site

Orem, UT United States
  Connect »

Axsome Study Site

Charlottesville, VA United States
  Connect »

Axsome study site

Bellevue, WA United States
  Connect »

Axsome study site

Spokane, WA United States
  Connect »

Axsome study site

Caulfield, Australia
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.